Allergy · 2009 · 31 citations · 12 references
Life SciencesInfectious DiseasesPharmacologyAllergyClinical ImmunologyHypersensitivityAntibiotic Allergy AssessmentDrug AllergyIge-mediated AllergyImmediate HypersensitivityPatch TestingBeta-lactam Allergy AssessmentCross-reactivity Among Beta-lactam AntibioticsIge-mediated ActivationIge-mediated Antibiotic AllergyIge-mediated HypersensitivityIge-mediated MechanismsImmunoglobulin E-mediated ResponsesIntradermal Allergy Testing
BACKGROUND: Administration of imipenem-cilastatin to patients with IgE-mediated hypersensitivity to beta-lactams has always been considered potentially harmful. Recent studies have demonstrated the tolerability of carbapenems (imipenem-cilastatin and meropenem) in patients with IgE-mediated hypersensitivity to beta-lactams; there are no studies on this topic regarding patients with cell-mediated allergy to beta-lactams. The aim of this study is to assess cross-reactivity and tolerability of imipenem in patients with cell-mediated allergy to beta-lactams. METHODS: From our database we selected 73 patients with cell-mediated allergy to beta-lactams, diagnosed by means of immediate-type skin tests, delayed reading intradermal tests, patch tests and detection of specific IgE. Patients with negative patch tests with imipenem-cilastatin underwent an intramuscular test dosing. RESULTS: Our patients had a total of 94 nonimmediate reactions to penicillins. All patients had positive patch tests and/or delayed reading intradermal tests for at least one of the penicillin reagent tested and negative immediate-type skin tests and specific IgE. Four patients out of 73 had a positive patch tests to at least one penicillin reagent and imipenem-cilastatin showing cross-reactivity. Sixty-four patients underwent the imipenem-cilastatin intramuscular test dosing and none of them had a clinical reaction. CONCLUSIONS: Our rate of cross-reactivity between imipenem-cilastatin and other beta-lactams was 5.5%. This result is different from previous findings and this may be explained by the fact that we investigated patients with cell-mediated allergy to beta-lactams. Patients with cell-mediated allergy to beta-lactams should undergo patch tests and a tolerance challenge test before treatment with imipenem-cilastatin.
12
General considerations for skin test procedures in the diagnosis of drug hypersensitivity
Knut Brockow, Antonino Romano, M. Blanca et al. · Allergy · 2002 · 701 citations
Imipenem cross-reactivity with penicillin in humans
Andrew Saxon, Daniel C. Adelman, Richard Hajdu et al. · Journal of Allergy and Clinical Immunology · 1988 · 165 citations
Skin test evaluation in nonimmediate allergic reactions to penicillins
Marı́a José Torres, Elena Sánchez-Sabaté, Juan C. Álvarez et al. · Allergy · 2004 · 102 citations
William A. Prescott, Daryl D. DePestel, Jeffrey J. Ellis et al. · Clinical Infectious Diseases · 2004 · 94 citations · Full text